Background The Hutterite Brethren are a genetic isolate characterized by high indices of relatedness and a communal agrarian lifestyle. We hypothesized that variation of the angiotensinogen (AGT) and angiotensin-converting enzyme (ACE) genes would be associated with variation in resting blood pressure in this group. We also hypothesized that the association would depend on the sex of the subjects.
Background The Hutterite Brethren are a genetic isolate characterized by high indices of relatedness and a communal agrarian lifestyle. We hypothesized that variation of the angiotensinogen (AGT) and angiotensin-converting enzyme (ACE) genes would be associated with variation in resting blood pressure in this group. We also hypothesized that the association would depend on the sex of the subjects.
Methods and Results In 741 Hutterites, we measured blood pressure in quadruplicate and analyzed DNA for genotypes of an insertion/deletion (I/D) polymorphism of ACE and of two protein polymorphisms of AGT, namely, M235T and T174M. We tested for association between variation in systolic and diastolic blood pressures and genotypic class. We observed C omplex quantitative traits such as blood pressure (BP) are considered to be influenced by both genetic and nongenetic factors.' Approaches to analyze the genetic determinants of interindividual variation in BP must take into account both the number of gene products that contribute to pathogenesis and also the interactions of the gene products within biochemical and physiological pathways.' The identification of major genetic determinants of BP should be easier in closely related subjects than in unrelated subjects for several reasons. First, members of a geographic or religious isolate have a similar genetic background and comprise a relatively homogeneous gene pool. This should permit experimental control over background genetic variation. Second, if the sample has arisen from a few founders, then the total number of alleles for a gene in the pool is expected to be small. This could help identify major genes that have a significant effect on BP, since the number of functionally relevant mutations in a genetic isolate is also expected to be small. Third, the high degree of relatedness between group members increases the likelihood that some subjects will carry an allele that is identical by descent. Thus, a recessive effect of a candidate gene on BP might be more easily identified.2 Finally, the sharing of environmental factors among group members should help reduce the nongenetic component of phenotypic variation.
The Hutterite Brethren are a North American religious genetic isolate. 3 We have previously identified significant associations between candidate genes in lipoprotein metabolism and variation in plasma lipoproteins in the Hutterites.4 The Hutterites are a useful sample for the study of genetic determinants of quantitative traits such as plasma lipoproteins or BP because their founding gene pool is small and their indices of relatedness are high.4 DNA variation of the angiotensin-converting enzyme (ACE) gene in a noncoding region of the gene has been associated with variation in plasma ACE levels,5 coronary heart disease (CHD),6,7 and longevity.8 DNA variants of the angiotensinogen (AGT) gene underlying angiotensinogen protein polymorphism, particularly M235T and T174M, have been associated with hypertensive phenotypes.9"0 In addition, the genotype-phenotype association is modulated by gender since the expression of the hypertensive phenotype as preeclampsia in women was associated with the M235 variant of AGT.10 Therefore, we were also interested in determining the effect of gender on genotype-phenotype associations in the Hutterites. The current study had two major objectives: (1) 20 The distribution of SBP and DBP was significantly nonnormal in this data set. Therefore, for parametric statistical analyses, each variable was transformed and subjected to analysis of normality. The reciprocal of the square root was used for SBP and the natural logarithm was used for DBP; after these transformations, the distribution of the variables was not significantly different from normal (data not shown).
The transformed variables were used for parametric statistical analyses, but the nontransformed values are presented in the tables.
ANOVA was performed using the general linear models (GLM) procedure to determine the sources of variation for biochemical traits, with F tests computed from the type III sums of squares.20 This form of sum of squares is applicable to unbalanced study designs. Dependent variables were transformed for SBP and DBP. Independent variables included in the ANOVA were age, log BMI, current treatment status with antihypertensive agents ("treatment" or "no treatment"), and colony of origin, with the latter variable included to correct for contribution to variation that was related to other shared genetic and environmental factors. Also included as independent variables were genotypes of ACE I/D and AGT codons 235 and 174. Since we wished to identify significant genegender interactions, we included interaction terms with gender for each genotype system. When a significant association was identified within the whole group, baseline traits among individuals classified by genotype were subsequently compared using a nonparametric test for significant differences between groups (Kruskal-Wallis test, V2 approximation, NPAR1WAY routine20).
When a significant genotype-gender interaction term was identified within the whole group, the ANOVA was repeated for each sex separately using the GLM procedure to determine the sources of variation for biochemical traits, with F tests computed from the type III sums of squares. Dependent variables were transformed SBP and DBP. Independent variables included in the ANOVA were age, log BMI, treatment with antihypertensive agents, and colony of origin.
Any significant genotype-phenotype association that was detected by ANOVA was tested independently using V2
analysis. Subjects were classified as being hypertensive by fulfilling either of the following criteria: (1) (2 of 7), respectively.
Discussion
The principal finding of this study in Hutterites is the identification of an association between AGT genetic variation and differences in SBP that appear to be gender specific. We found a significant association between variation of SBP within the normal range and variation of AGT codon 174 in men but not in women from a genetically isolated population that was ascertained from CHD risk factor screening. We also found that while the AGT M174 variant was significantly associated with hypertension in male subjects, it was not associated with hypertension in female subjects.
The AGT M174 variant has been found at higher frequency in hypertensive subjects than in normal control subjects in North American and Parisian hypertensive sibling pairs. Tables 1 and 3 for definitions of abbreviations.
SBP level in men homozygous for the AGT T174 variant. Thus, the AGT M174 variant was associated with a higher baseline BP within the normal range and has a codominant effect with T174 on resting SBP. Its significant association with hypertension in the Hutterites and also in study samples from Paris and Salt Lake City9 suggest that it might predispose carriers to a slightly higher baseline BP. Phenotypic hypertension might then develop in AGT M174 carriers when secondary genetic or environmental factors are present.
Jeunemaitre et a19 found that variation of AGT codon 235 was also strongly associated with severe hypertension. They demonstrated that the AGT T235 variant was significantly more frequent in severely hypertensive index cases compared with normotensive control subjects (0.51 versus 0.36). Bennett et a122 subsequently found in a case-control study in Caucasians with severe familial essential hypertension that the AGT T235 variant was not significantly increased compared with normotensive control subjects. Thus, the results of Jeunemaitre et a19 contrast with whereas the results of Bennett et a122 are consistent with our finding that variation of AGT codon 235 was not significantly associated with BP in a predominantly normotensive Hutterite sample. The reasons for these discrepancies may relate to fundamental genetic differences in the study samples, within which subjects were ascertained using different criteria. The strong association of T235 with hypertension in the Paris and Salt Lake City samples suggests that it is may be a factor predisposing to hypertension in carriers. Our results suggest that such predisposition might not be evident by studying resting BP. Also, the expression of phenotypic hypertension in AGT T235 carriers might also require the presence of secondary genetic or environmental factors that were absent in our sample. Alternatively, since there can be strong linkage disequilibrium between alleles at AGT codons 235 and 174, the significance of any allelic association with phenotype could be due to linkage disequilibrium with another functionally relevant allele. While we demonstrated strong linkage disequilibrium between alleles of codons 235 and 174 in our Hutterite sample, only alleles of codon 174 were significantly associated with variation in resting SBP, suggesting that in this group alleles at codon 235 were not associated with resting SBP either independently or through linkage with codon 174. However, the linkage disequilibrium was not complete and was due to a higher than expected frequency of the M235 and T174 alleles and not between the other alleles that have been associated with higher BP.
Gender differences in AGT-associated hypertension have been reported. Both AGT T235 and M174 were significantly more prevalent in female hypertensive subjects than in control subjects,9 but no linkage with either variant was found among sibling pairs of female hypertensive subjects. The authors did not use a statistical model that would specifically identify a gender-specific modulation of the AGT-associated predisposition. However, they hypothesized that AGT contributes to hypertension indirectly in women. They postulated that an estrogen-related factor might mediate the impact of the AGT-associated genetic predisposition.9 The contention that gender and sex hormones could modulate the expression of AGT-associated hypertension was supported by the subsequent observation that AGT T235 was significantly more frequent in Caucasian women with preeclampsia and pregnancy-induced hypertension compared with normotensive pregnant control subjects (0.65 versus 0.40).10 Taken together, these data suggest that gender appears to modulate the expression of both AGT-associated hypertension and AGT-associated variation in normal BP.
Variation at AGT codon 235 has also been associated with variation in plasma angiotensinogen level, providing a possible biochemical mechanism linking the genomic DNA variation with the hypertension phenotype.9 Among all subjects with hypertension, AGT M235/M235 homozygotes had the lowest mean plasma angiotensinogen levels, AGT M235/T235 heterozygotes had intermediate mean plasma angiotensinogen levels, and AGT T235/T235 homozygotes had the highest mean plasma angiotensinogen levels. When men and women were analyzed separately, the difference between genotypic classes was much more remarkable and statistically significant in women. These data further support the notion that gender modulates the impact of AGT genetic variation on both intermediate phenotypes, such as plasma angiotensinogen levels, and distant phenotypes, such as BP.
It has been postulated that elevations in plasma or tissue levels of AGT associated with specific structural AGT variants might result in increased baseline production of angiotensin II. Chronically high levels of angiotensin II might increase vascular tone, resulting in an increase in resting BP. Our data would suggest that gender might have an impact on the association between AGT-associated variation in resting BP. Jeunemaitre et a19 have also postulated that elevated baseline angiotensinogen levels might also affect the reactivity of the renin-angiotensin system with an altered homeostatic setpoint in predisposed individuals. In the presence of additional pathophysiological stresses such as hypervolemia, increased sympathetic nervous system stimulation, or increased cardiac output, this predisposition might lead to the development of overt clinical hypertension. Regression analysis determined that 3.1% of the total variation in SBP was accounted for by genetic variation of AGT codon 174. This was comparable to the proportion of total variation in SBP that was accounted for by BMI, which was 5.3%. However, it was less than the proportion of variation that was accounted for by medication status and colony of origin, which were 16.9% and 7.9%, respectively. The genetic contribution to interindividual variation in BP has been estimated at 20% to 40%.1 Thus, in these Hutterite men, a substantial part of the genetic component of interindividual variation in BP appears to have been determined by genetic variation of AGT. The relatively high proportion of variation attributable to colony of origin, namely, 7.9%, could reflect additional shared genetic or environmental factors that determine interindividual variation in BP in this study sample.
Summary
We have observed that genetic variation in AGT was associated with interindividual variation in SBP only in men. This provides support for the previous observations of association between structural variation in AGT and BP-related phenotypes such as plasma angiotensinogen levels and overt hypertension. Studies using highly related subjects can help apportion the relative contribution of various genetic factors to a complex phenotype like BP. Newer approaches to rapidly screen for regions of genomic DNA that are identical by descent25 and to perform combined segregation and linkage analysis in highly related populations26 could further help to identify new genes that are important in polygenic diseases such as hypertension and help to identify high-risk individuals who are candidates for interventions.
